autoimmunity-exemplar

Exemplar Projects

Novel combination therapy for rheumatoid arthritis (Prof. Mike Ehrenstein - UCL).
A mechanistic understanding of combination therapy approach in the setting of PR3 ANCA-associated vasculitis (COMBIVAS, led by Dr David Jayne - Cambridge).

EMINENT News

September 2020

A new project titled 'Investigating the role of LAG3 in regulatory and effector T cells in systemic lupus erythematosus' led by Prof. Mike Ehrenstein (UCL) in collaboration with Dr Ruth Tarzi and Dr Naren Srinivasan at GSK was awarded by the EMINENT Scientific Research Board.